Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements

Haemophilia

Volumn 20, Issue 4, 2014, Pages 550-558

  Trossaert, M ^a   Lienhart, A ^b   Nougier, C ^b   Fretigny, M ^b   Sigaud, M ^a   Meunier, S ^b   Fouassier, M ^a   Ternisien, C ^a   Negrier, C ^b,c   Dargaud, Y ^b,c  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c University Lyon 1   (France)

Author keywords

Bleeding; Bleeding score; FVIII; Genotype; Mild haemophilia A; Thrombin generation

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADULT; ARTICLE; BLOOD CLOTTING FACTOR 8 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENE; GENE MUTATION; HEMOPHILIA A; HUMAN; MILD HEMOPHILIA A; MULTICENTER STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SCORING SYSTEM; BLEEDING; BLOOD CLOTTING; CLINICAL CHEMISTRY; COMPLICATION; DRUG EFFECTS; GENETICS; GENOTYPE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; YOUNG ADULT;

ADULT; BLOOD COAGULATION; CLINICAL CHEMISTRY TESTS; FACTOR VIII; GENOTYPE; HEMOPHILIA A; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; YOUNG ADULT;

EID: 84904767446     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12381     Document Type: Article

References (30)

1. Franchini M, Favaloro EJ, Lippi G. MHA. J Thromb Haemost 2010; 8: 421-32.
2. White GC, Rosendaal FR, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in haemophilia. Recommendations of the scientific subcommittee on factor VIII and factor IX of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001; 85: 560.
3. Poulsen AL, Pedersen LH, Hvas AM, Poulsen LH, Thykjaer H, Ingerslev J. Assay discrepancy in mild haemophilia A: entire population study in a National Haemophilia Centre. Haemophilia 2009; 15: 285-9.
4. Duncan EM, Duncan BM, Tunbridge LJ, Lloyd JV. Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of patients with haemophilia A. Br J Haem 1994; 87: 846-8.
5. Cid AR, Calabuig M, Cortina V et al. One-stage and chromogenic FVIII: C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype. Haemophilia 2008; 14: 1049-54.
6. Bowyer AE, Goodeve AC, Liesner R, Mumford AD, Kitchen S, Makris M. p Tyr365Cys change in factor VIII: haemophilia A, but not as we know it. Br J Haem 2011; 154: 618-25.
7. Pipe SW, Saenko EL, Eickhorst AN, Kemball-Cook G, Kaufman RJ. Haemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein- protein interactions within the triplicated A domains of thrombin-activated factor VIIIa. Blood 2001; 97: 685-91.
8. Rudzki Z, Duncan EM, Casey GJ, Neumann M, Favaloro EJ, Lloyd JV. Mutations in a subgroup of patients with mild haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII:C methods. Br J Haematol 1996; 94: 400-6.
9. Jacquemin M, Lavend'homme R, Benhida A et al. A novel cause of mild/moderate haemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor. Blood 2000; 96: 958-65.
10. Haidl H, Cimenti C, Leschnik B, Zach D, Muntean W. Age-dependency of TG measured by means of calibrated automated thrombography (CAT). Thromb Haemost 2006; 95: 772-5.
11. Rodeghiero F, Tosetto A, Abshire T et al.; ISTH/SSC Joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessmenttool: a standardizedquestionnaire and a proposal for a newbleedingscore for inherited bleeding disorders. J Thromb Haemost 2010; 8: 2063-5.
12. Tosetto A, Castaman G, Plug I, Rodeghiero F, Eikenboom J. Prospective evaluation of the clinical utility of quantitativeleeding severity assessment in patients referred for hemostatic evaluation. J Thromb Haemost 2011; 9: 1143-9.
13. Hemker HC, Giesen P, Al Dieri R et al. Calibrated automated TG measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
14. Hemker HC, Beguin S. Phenotyping the clotting system. Thomb Haemost 2000; 84: 747-51.
15. Trossaert M, Regnault V, Sigaud M, Boisseau P, Fressinaud E, Lecompte T. MHA with factor VIII assay discrepancy: using TG assay to assess the bleeding phenotype. Thromb Haemost 2008; 6: 486-93.
16. De Moerloose P, Levrat E, Fontana P, Boehlen F. Diagnosis of mild bleeding disorders. Swiss Med WKLY 2009; 139: 327-32.
17. Dargaud Y, Beguin S, Lienhart A et al. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost 2005; 93: 475-80.
18. Santagostino E, Mancuso ME, Tripodi A et al. Severe haemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile. J Thromb Haemost 2010; 8: 737-43.
19. Gilmore R, Harmon S, Gannon C, Byrne M, O'Donnell JS, Jenkins PV. TG in haemophilia A patients with mutations causing factorVIII assay discrepancy. Haemophilia 2010; 16: 671-4.
20. van Veen JJ, Gatt A, Bowyer AE, Cooper PC, Kitchen S, Makris M. Calibrated automated TG and modified thromboelastometry in haemophilia A. Thromb Res 2009; 123: 895-901.
21. Bowyer AE, Van Veen JJ, Goodeve AC, Kitchen S, Makris M. Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A. Haematologica 2013; 98: 1980-7.
22. Trossaert M, Boisseau P, Quemener A et al. Prevalence, biological phenotype and genotype in moderate/MHA with discrepancy between one-stage and chromogenic factor VIII activity. J Thromb Haemost 2011; 9: 524-30.
23. Schwaab R, Oldenburg J, Kemball-Cook G et al. Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family. Brit J Haematol 2000; 109: 523-8.
24. Parquet-Gernezet A, Mazurier C, Goudemand J. Functional and immunological assays of FVIII in 133 haemophiliacs-characterization of a subgroup of patients with mild haemophilia A and discrepancy in 1- and 2-stage assays. Thromb Haemost 1988; 59: 202-6.
25. Keeling DM, Sukhu K, Kemball-Cook G, Waseem N, Bagnall R, Lloyd JV. Diagnostic importance of the two-stage factor VIII: C assay demonstrated by a case of mild haemophilia associated with His 1954->Leu substitution in the factor VIII A3 domain. Br J Haematol 1999; 105: 1123-6.
26. Nesbitt I, Kinks J, Sampson B et al. Discrepant one and two stage FVIII assays are very common in mild haemophilia A: correlation with FVIII gene mutations. Thromb Haemost 2001; 84: Abstract 195.
27. Rodgers SE, Duncan EM, Barbulescu DM, Quinn DM, Lloyd JV. In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results. Br J Haematol 2007; 136: 138-45.
28. Dargaud Y, Lienhart A, Negrier C. Prospective assessment of TG test for dose monitoring of bypassing therapy in haemophilia patients with inhibitors undergoing elective surgery. Blood 2010; 116: 5734-7.
29. Dargaud Y, Luddington R, Gray E et al. Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study. Br J Haematol 2007; 139: 303-9.
30. Dargaud Y, Wolberg AS, Luddington R et al. Evaluation of a standardized protocol for TG measurement using the calibrated automated thrombogram: an international multicentre study. Thromb Res 2012; 130: 929-34.